tiprankstipranks
Metagenomi, Inc. (MGX)
:MGX
US Market

Metagenomi, Inc. (MGX) Financial Statements

Compare
878 Followers

Metagenomi, Inc. Financial Overview

Metagenomi, Inc.'s market cap is currently $91.31M. The company's EPS TTM is $-2.501; its P/E ratio is ―; Metagenomi, Inc. is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.75. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 44.76M$ 17.20M$ 243.00K
Gross Profit$ -49.65M$ 15.47M$ -144.00K
Operating Income$ -78.49M$ -44.64M$ -23.95M
EBITDA$ -56.02M$ -39.19M$ -20.75M
Net Income$ -68.25M$ -43.59M$ -21.44M
Balance Sheet
Cash & Short-Term Investments$ 271.18M$ 362.13M$ 108.15M
Total Assets$ 364.84M$ 414.49M$ 141.99M
Total Debt$ 48.23M$ 18.57M$ 48.93M
Net Debt$ -92.37M$ -165.87M$ 9.63M
Total Liabilities$ 500.43M$ 488.91M$ 174.54M
Stockholders' Equity$ -135.58M$ -74.43M$ -32.54M
Cash Flow
Free Cash Flow$ -101.22M$ 15.75M$ 21.35M
Operating Cash Flow$ -91.41M$ 29.72M$ 24.26M
Investing Cash Flow$ 45.73M$ -122.20M$ -74.32M
Financing Cash Flow$ 1.01M$ 239.59M$ 39.92M
Currency in USD

Metagenomi, Inc. Earnings and Revenue History

Metagenomi, Inc. Debt to Assets

Metagenomi, Inc. Cash Flow

Metagenomi, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis